scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10689-017-9978-9 |
P698 | PubMed publication ID | 28285342 |
P50 | author | Ielizaveta Gorodetska | Q86490820 |
Nataliia M Khranovska | Q92988639 | ||
Mariia Inomistova | Q95966407 | ||
Zoia Rossokha | Q95966410 | ||
Svitlana Kyriachenko | Q95966412 | ||
Svitlana Serga | Q56334616 | ||
Iryna Kozeretska | Q56334617 | ||
Ludmila Ostapchenko | Q56952052 | ||
P2093 | author name string | O Popova | |
A Peresunko | |||
H Salomakhina | |||
N Kmit' | |||
N Tsip | |||
O Kolesnik | |||
O Manzhura | |||
O Skachkova | |||
S Demydov | |||
T Lahuta | |||
V Svintsitsky | |||
P2860 | cites work | Simple and rapid detection of BRCA1 and BRCA2 mutations by multiplex mutagenically separated PCR | Q78077814 |
High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer | Q84732910 | ||
Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia | Q24680712 | ||
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation | Q28207617 | ||
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 | Q28212276 | ||
Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary | Q33900686 | ||
Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2. | Q34103057 | ||
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer | Q34145544 | ||
Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing | Q34228853 | ||
On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations | Q34705352 | ||
Breast cancer risk among male BRCA1 and BRCA2 mutation carriers | Q34718829 | ||
Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control | Q36117690 | ||
The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine | Q36161162 | ||
Cancer risks among BRCA1 and BRCA2 mutation carriers | Q36610578 | ||
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients | Q37147699 | ||
The contribution of BRCA1 and BRCA2 to ovarian cancer | Q37453854 | ||
High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia | Q43522641 | ||
Hereditary ovarian cancer in Poland. | Q43683502 | ||
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada | Q44116893 | ||
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases | Q44221699 | ||
BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. | Q45906306 | ||
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. | Q46922759 | ||
Cultural aspects of healthy BRCA carriers from two ethnocultural groups | Q47656975 | ||
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation. | Q55042194 | ||
Mutational analysis of theBRCA1 gene in 30 Czech ovarian cancer patients | Q61896436 | ||
High frequency and allele-specific differences of BRCA1 founder mutations in breast cancer and ovarian cancer patients from Belarus | Q62583327 | ||
BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases | Q74449532 | ||
P433 | issue | 4 | |
P921 | main subject | Ukraine | Q212 |
ovarian cancer | Q172341 | ||
P304 | page(s) | 471-476 | |
P577 | publication date | 2017-03-11 | |
P1433 | published in | Familial Cancer | Q15761917 |
P1476 | title | Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine. | |
P478 | volume | 16 |